Medical ProductsCompany
Akorn - 4 New Drug Applications Ownership
Who owns Akorn - 4 New Drug Applications?
Akorn - 4 New Drug Applications is owned by Allergan. It was acquired on April 17, 2014.
Akorn - 4 New Drug Applications Business Overview
Where is Akorn - 4 New Drug Applications headquartered?
Akorn - 4 New Drug Applications is headquartered in United States.
What sector is Akorn - 4 New Drug Applications in?
Akorn - 4 New Drug Applications is a medical products company.
Medical Products M&A Summary in 2014
Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2014. The largest medical products acquisition in 2014 was Covidien - which was acquired by Medtronic for $42.9B.
Join Mergr to view all 217 acquisitions of medical products companies in 2014, including 24 acquisitions by private equity firms, and 193 by strategics.